These are additional notices applicable to this website.
The Ohio State University
The use of sarcolipin (SLN) as a novel target to increase metabolism and treat obesity.
©2016 The Ohio State University
Technology Commercialization Office
1524 North High Street | Columbus, Ohio 43201
Contact: firstname.lastname@example.org | 614.292.1315
Webmaster | Page maintained by TCO
1524 N. High Street
Columbus, Ohio 43201